Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 14/20 | 0.69 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.69 |
| ▸ | NQO2 | P16083 | 4/20 | 0.69 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.68 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.68 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.61 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.56 |
| ▸ | HTR2B | P41595 | 2/20 | 0.54 |
| ▸ | HTR2C | P28335 | 1/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23950254 | 0.94 | HDAC3 (0.71) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL23925220 | 0.93 | HDAC3 (0.73) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL23950141 | 0.89 | MTNR1A (0.69) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL16068348 | 0.85 | HDAC3 (0.73) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL8717163 | 0.85 | MTNR1A (0.74) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL23950140 | 0.83 | MTNR1A (0.71) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL5144427 | 0.82 | MTNR1A (1.00) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL16068372 | 0.82 | HDAC3 (0.68) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL1067941 | 0.80 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2HDAC3HDAC6 | |
| SCHEMBL30852855 | 0.80 | MTNR1A (0.78) | MTNR1AMTNR1BNQO2HDAC3HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323917-A1 | MELATONIN DERIVATIVES, METHOD THEREOF, AND USE THEREOF | XIAMEN NUOKANGDE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323917-A1 | MELATONIN DERIVATIVES, METHOD THEREOF, AND USE THEREOF | MTNR1A, MTNR1B, INMT | MTNR1A 1/4885MTNR1B 2/4885NQO2 1248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.